Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,499 | -22,184 | -16,542 | -4,532 | -20,530 |
| Depreciation Amortization | 1,860 | 1,279 | 859 | 422 | 2,171 |
| Accounts payable and accrued liabilities | 1,287 | 602 | -518 | -891 | 682 |
| Other Working Capital | -4,573 | -3,536 | -4,381 | -4,059 | 7,331 |
| Other Operating Activity | 7,980 | 8,328 | 9,097 | 1,167 | -63 |
| Operating Cash Flow | $-20,944 | $-15,511 | $-11,485 | $-7,892 | $-10,410 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,702 | -1,272 | -1,056 | -320 | -1,170 |
| Purchase Of Investment | -36,578 | -9,981 | -9,981 | -3,392 | -35,265 |
| Sale Of Investment | 35,188 | 29,467 | 20,361 | 8,586 | 29,323 |
| Other Investing Activity | 85 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,007 | $18,215 | $9,324 | $4,874 | $-7,111 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,073 | 1,054 | 1,261 | 633 | 2,535 |
| Debt Repayment | -5,429 | -4,294 | -736 | -366 | -2,224 |
| Common Stock Issued | 37,424 | 38,162 | 237 | 48 | 329 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 13,991 |
| Financing Cash Flow | $34,068 | $34,922 | $762 | $315 | $14,631 |
| Beginning Cash Position | 7,588 | 7,588 | 7,588 | 7,588 | 10,478 |
| End Cash Position | 17,705 | 45,213 | 6,189 | 4,884 | 7,588 |
| Net Cash Flow | $10,117 | $37,625 | $-1,399 | $-2,704 | $-2,890 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,944 | -15,511 | -11,485 | -7,892 | -10,410 |
| Capital Expenditure | -1,704 | -1,273 | -1,056 | -320 | -1,170 |
| Free Cash Flow | -22,648 | -16,785 | -12,542 | -8,212 | -11,580 |